BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FWDI
4026
Forward Industries Inc
FWDI
$319M
| $592K | ﹤0.01% |
45,585
-31
| -0.1% | -$364 |
|
4027
Townsquare Media
TSQ
$118M
| $591K | ﹤0.01% |
132,161
+13,401
| +11% | +$61.3K |
|
4028
Amplify Energy
AMPY
$166M
| $590K | ﹤0.01% |
479,447
-346,400
| -42% | -$415K |
|
|
SPRT
4029
DELISTED
support.com, Inc.
SPRT
| $590K | ﹤0.01% |
418,516
-50,286
| -11% | -$66.7K |
|
4030
Destination XL Group
DXLG
$35.4M
| $589K | ﹤0.01% |
906,294
-93,955
| -9% | -$41.7K |
|
4031
Reading International Class A
RDI
$34.3M
| $587K | ﹤0.01% |
138,025
-795,333
| -85% | -$3M |
|
|
STRR
4032
Star Equity Holdings
STRR
$41.7M
| $584K | ﹤0.01% |
66,386
-8,324
| -11% | -$75.3K |
|
4033
Tecnoglass Holdings Inc.
TGLS
$1.96B
| $583K | ﹤0.01% |
107,030
+40,733
| +61% | +$171K |
|
|
PMD
4034
DELISTED
Psychemedics Corporation
PMD
| $581K | ﹤0.01% |
104,717
+4,265
| +4% | +$23.8K |
|
4035
Invesco Bond Fund
VBF
$169M
| $579K | ﹤0.01% |
+28,914
| New | +$557K |
|
|
ACER
4036
DELISTED
Acer Therapeutics Inc
ACER
| $573K | ﹤0.01% |
166,796
-222,930
| -57% | -$629K |
|
4037
BioNTech
BNTX
$23.5B
| $560K | ﹤0.01% |
8,390
-3,051
| -27% | -$152K |
|
|
SEEL
4038
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $560K | ﹤0.01% |
144
+33
| +30% | +$110K |
|
|
DVD
4039
DELISTED
Dover Motorsports
DVD
| $557K | ﹤0.01% |
358,921
+23,230
| +7% | +$31.3K |
|
4040
Lantronix
LTRX
$266M
| $554K | ﹤0.01% |
149,316
+11,631
| +8% | +$36.3K |
|
|
PTE
4041
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $554K | ﹤0.01% |
17,841
-32,767
| -65% | -$871K |
|
4042
Astrotech Corp
ASTC
$17.8M
| $546K | ﹤0.01% |
6,389
| – | – |
|
|
MARK
4043
DELISTED
Remark Holdings, Inc.
MARK
| $546K | ﹤0.01% |
23,119
+237
| +1% | +$3.65K |
|
|
IDXG
4044
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $545K | ﹤0.01% |
117,152
| – | – |
|
4045
Coda Octopus Group
CODA
$120M
| $544K | ﹤0.01% |
105,720
-233,332
| -69% | -$1.23M |
|
4046
Tenax Therapeutics
TENX
$503M
| $543K | ﹤0.01% |
374
| – | – |
|
|
VIRX
4047
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $543K | ﹤0.01% |
58,905
-6,529
| -10% | -$98.4K |
|
|
BIOR
4048
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $540K | ﹤0.01% |
+240
| New | +$654K |
|
4049
SCYNEXIS
SCYX
$52M
| $536K | ﹤0.01% |
8,927
-2,983
| -25% | -$202K |
|
|
ACH
4050
DELISTED
Alum Corp of China Ltd
ACH
| $528K | ﹤0.01% |
112,356
+15,311
| +16% | +$76.4K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.